CaMK2 modulators and their use in medicine

Publikation: Patent

The present disclosure relates to compounds which bind Ca2+/calmodulin dependent protein kinase II. It also relates to such compounds for use in the treatment of CNS disorders with sleep disturbances and acute brain injury.
OriginalsprogEngelsk
IPCA61K31/4164,A61K31/4178,A61P25/00,C07D277/06,C07D277/12,C07D277/56,C07D417/04,C07D417/10
PatentnummerWO2023170024A1
Journaliseringsdato01/01/1970
Land/OmrådeUSA
PrioritetsnummerUS202263318852P
StatusUdgivet - 2023

Links

ID: 382744669